Lifecore Biomedical Participates in Industry Conferences to Expand Network

CHASKA, Minn., Oct. 07, 2026 /CourierPR/ -- Lifecore Biomedical, a fully integrated contract development and manufacturing organization (CDMO), is set to participate in three upcoming industry conferences, aiming to expand its network and discuss its services with potential customers.

The company will be present at CDMO Live Americas, an event focused on partnership opportunities in drug development. Lifecore will occupy booth C19 from October 19 to 21, 2026, in Boston, MA. Additionally, the company will have a booth at the American Pharma Manufacturing & Outsourcing Summit, located at booth 109 on October 29 and 30, 2026, also in Boston, MA.

Ryan Swanson, Ph.D., director of Lifecore’s Manufacturing Science & Technology (MS&T) group, will contribute to the summit as a panel speaker.

Lifecore Biomedical, with over 40 years of experience in the development, fill and finish of sterile injectable pharmaceutical products, including complex formulations, is leveraging these conferences to engage with prospective customers. The company offers a range of services, from process development to manufacturing, and is particularly known for its injectable-grade hyaluronic acid.

At the American Pharma Manufacturing & Outsourcing Summit, Lifecore will be available for meetings with interested parties.

Lifecore Biomedical is a leading manufacturer of premium, injectable-grade hyaluronic acid and brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies. The company's participation in these conferences underscores its commitment to expanding its reach and collaborating with industry leaders.